CNP-201 in Subjects With Peanut Allergy
Clinical trial NCT05250856 · TERMINATED
Trial details
- NCT number
- NCT05250856
- Sponsor
- COUR Pharmaceutical Development Company, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-14
- Primary completion
- 2023-12-12
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.